1054 related articles for article (PubMed ID: 33275517)
41. Sex-based differences in severity and mortality in COVID-19.
Alwani M; Yassin A; Al-Zoubi RM; Aboumarzouk OM; Nettleship J; Kelly D; Al-Qudimat AR; Shabsigh R
Rev Med Virol; 2021 Nov; 31(6):e2223. PubMed ID: 33646622
[TBL] [Abstract][Full Text] [Related]
42. How tetraspanin-mediated cell entry of SARS-CoV-2 can dysregulate the shedding of the ACE2 receptor by ADAM17.
Healy EF
Biochem Biophys Res Commun; 2022 Feb; 593():52-56. PubMed ID: 35063769
[TBL] [Abstract][Full Text] [Related]
43. Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men.
Samuel RM; Majd H; Richter MN; Ghazizadeh Z; Zekavat SM; Navickas A; Ramirez JT; Asgharian H; Simoneau CR; Bonser LR; Koh KD; Garcia-Knight M; Tassetto M; Sunshine S; Farahvashi S; Kalantari A; Liu W; Andino R; Zhao H; Natarajan P; Erle DJ; Ott M; Goodarzi H; Fattahi F
Cell Stem Cell; 2020 Dec; 27(6):876-889.e12. PubMed ID: 33232663
[TBL] [Abstract][Full Text] [Related]
44. Role of angiotensin-converting enzyme 2 in neurodegenerative diseases during the COVID-19 pandemic.
Li Z; Xu X; Yang M; Feng J; Liu C; Yang C
Aging (Albany NY); 2020 Nov; 12(23):24453-24461. PubMed ID: 33197881
[TBL] [Abstract][Full Text] [Related]
45. SARS-CoV-2/human interactome reveals ACE2 locus crosstalk with the immune regulatory network in the host.
Lite C; Ahmed SSSJ; Juliet M; Freddy AJ
Pathog Dis; 2021 Feb; 79(2):. PubMed ID: 33469663
[TBL] [Abstract][Full Text] [Related]
46. Possible Transmission Flow of SARS-CoV-2 Based on ACE2 Features.
Hassan SS; Ghosh S; Attrish D; Choudhury PP; Aljabali AAA; Uhal BD; Lundstrom K; Rezaei N; Uversky VN; Seyran M; Pizzol D; Adadi P; Soares A; El-Aziz TMA; Kandimalla R; Tambuwala MM; Azad GK; Sherchan SP; Baetas-da-Cruz W; Takayama K; Serrano-Aroca Á; Chauhan G; Palu G; Brufsky AM
Molecules; 2020 Dec; 25(24):. PubMed ID: 33322198
[TBL] [Abstract][Full Text] [Related]
47. Potential Roles of the Renin-Angiotensin System in the Pathogenesis and Treatment of COVID-19.
Lu L; Liu X; Jin R; Guan R; Lin R; Qu Z
Biomed Res Int; 2020; 2020():7520746. PubMed ID: 33204713
[TBL] [Abstract][Full Text] [Related]
48. Functional Complexes of Angiotensin-Converting Enzyme 2 and Renin-Angiotensin System Receptors: Expression in Adult but Not Fetal Lung Tissue.
Franco R; Lillo A; Rivas-Santisteban R; Rodríguez-Pérez AI; Reyes-Resina I; Labandeira-García JL; Navarro G
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33339432
[TBL] [Abstract][Full Text] [Related]
49. Origin and genomic characteristics of SARS-CoV-2 and its interaction with angiotensin converting enzyme type 2 receptors, focusing on the gastrointestinal tract.
Galanopoulos M; Doukatas A; Gazouli M
World J Gastroenterol; 2020 Nov; 26(41):6335-6345. PubMed ID: 33244196
[TBL] [Abstract][Full Text] [Related]
50. Effect of Common Medications on the Expression of SARS-CoV-2 Entry Receptors in Kidney Tissue.
Saheb Sharif-Askari N; Saheb Sharif-Askari F; Alabed M; Tayoun AA; Loney T; Uddin M; Senok A; Al Heialy S; Hamoudi R; Kashour T; Alsheikh-Ali A; Hamid Q; Halwani R
Clin Transl Sci; 2020 Nov; 13(6):1048-1054. PubMed ID: 32799423
[TBL] [Abstract][Full Text] [Related]
51. ACE2: The key Molecule for Understanding the Pathophysiology of Severe and Critical Conditions of COVID-19: Demon or Angel?
Xiao L; Sakagami H; Miwa N
Viruses; 2020 Apr; 12(5):. PubMed ID: 32354022
[TBL] [Abstract][Full Text] [Related]
52. Systematic profiling of ACE2 expression in diverse physiological and pathological conditions for COVID-19/SARS-CoV-2.
Li Y; Xu Q; Ma L; Wu D; Gao J; Chen G; Li H
J Cell Mol Med; 2020 Aug; 24(16):9478-9482. PubMed ID: 32639084
[TBL] [Abstract][Full Text] [Related]
53. ACE2 Nascence, trafficking, and SARS-CoV-2 pathogenesis: the saga continues.
Badawi S; Ali BR
Hum Genomics; 2021 Jan; 15(1):8. PubMed ID: 33514423
[TBL] [Abstract][Full Text] [Related]
54. Critical ACE2 Determinants of SARS-CoV-2 and Group 2B Coronavirus Infection and Replication.
Adams LE; Dinnon KH; Hou YJ; Sheahan TP; Heise MT; Baric RS
mBio; 2021 Mar; 12(2):. PubMed ID: 33727353
[TBL] [Abstract][Full Text] [Related]
55. Angiotensin-converting enzyme 2 and kidney diseases in the era of coronavirus disease 2019.
Suh SH; Ma SK; Kim SW; Bae EH
Korean J Intern Med; 2021 Mar; 36(2):247-262. PubMed ID: 33617712
[TBL] [Abstract][Full Text] [Related]
56. Single-cell RNA sequencing analysis of human kidney reveals the presence of ACE2 receptor: A potential pathway of COVID-19 infection.
He Q; Mok TN; Yun L; He C; Li J; Pan J
Mol Genet Genomic Med; 2020 Oct; 8(10):e1442. PubMed ID: 32744436
[TBL] [Abstract][Full Text] [Related]
57. High expression of ACE2 in the human lung leads to the release of IL6 by suppressing cellular immunity: IL6 plays a key role in COVID-19.
Bao Z; Wang LJ; He K; Lin X; Yu T; Li J; Gong J; Xiang G
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):527-540. PubMed ID: 33506945
[TBL] [Abstract][Full Text] [Related]
58. Upregulation of the Renin-Angiotensin System Pathways and SARS-CoV-2 Infection: The Rationale for the Administration of Zinc-Chelating Agents in COVID-19 Patients.
Zamai L
Cells; 2021 Feb; 10(3):. PubMed ID: 33673459
[TBL] [Abstract][Full Text] [Related]
59. Polymorphisms of ACE (I/D) and ACE2 receptor gene (Rs2106809, Rs2285666) are not related to the clinical course of COVID-19: A case study.
Karakaş Çelik S; Çakmak Genç G; Pişkin N; Açikgöz B; Altinsoy B; Kurucu İşsiz B; Dursun A
J Med Virol; 2021 Oct; 93(10):5947-5952. PubMed ID: 34170561
[TBL] [Abstract][Full Text] [Related]
60. Dysregulation of COVID-19 related gene expression in the COPD lung.
Watson A; Öberg L; Angermann B; Spalluto CM; Hühn M; Burke H; Cellura D; Freeman A; Muthas D; Etal D; Belfield G; Karlsson F; Nordström K; Ostridge K; Staples KJ; Wilkinson T;
Respir Res; 2021 May; 22(1):164. PubMed ID: 34051791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
